Business Description
![Daiichi Sankyo Co Ltd Daiichi Sankyo Co Ltd logo](https://static.gurufocus.com/logos/0C00000Y8W.png?14)
Daiichi Sankyo Co Ltd
ISIN : JP3475350009
Description
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2023, approximately one third of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first US approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.04 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.28 | |||||
Interest Coverage | 28.62 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 5.6 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19 | |||||
3-Year EBITDA Growth Rate | 31.7 | |||||
3-Year EPS without NRI Growth Rate | 38.8 | |||||
3-Year FCF Growth Rate | 55.6 | |||||
3-Year Book Growth Rate | 9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 24.42 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.77 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.25 | |||||
9-Day RSI | 59.52 | |||||
14-Day RSI | 58.47 | |||||
6-1 Month Momentum % | 6.02 | |||||
12-1 Month Momentum % | 22.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.01 | |||||
Quick Ratio | 2.4 | |||||
Cash Ratio | 1.69 | |||||
Days Inventory | 323.72 | |||||
Days Sales Outstanding | 89.32 | |||||
Days Payable | 404.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.85 | |||||
Dividend Payout Ratio | 0.42 | |||||
3-Year Dividend Growth Rate | 22.8 | |||||
Forward Dividend Yield % | 1.01 | |||||
5-Year Yield-on-Cost % | 1.63 | |||||
Shareholder Yield % | 1.47 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.3 | |||||
Operating Margin % | 15.44 | |||||
Net Margin % | 13.58 | |||||
FCF Margin % | 25.98 | |||||
ROE % | 14.6 | |||||
ROA % | 7.9 | |||||
ROIC % | 13.68 | |||||
ROC (Joel Greenblatt) % | 46.68 | |||||
ROCE % | 13.17 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.47 | |||||
Forward PE Ratio | 48.17 | |||||
PE Ratio without NRI | 48.47 | |||||
Shiller PE Ratio | 83.57 | |||||
Price-to-Owner-Earnings | 18.99 | |||||
PEG Ratio | 3.88 | |||||
PS Ratio | 6.07 | |||||
PB Ratio | 6.06 | |||||
Price-to-Tangible-Book | 7.25 | |||||
Price-to-Free-Cash-Flow | 25.18 | |||||
Price-to-Operating-Cash-Flow | 19.13 | |||||
EV-to-EBIT | 34.29 | |||||
EV-to-Forward-EBIT | 35.9 | |||||
EV-to-EBITDA | 28.48 | |||||
EV-to-Forward-EBITDA | 28.42 | |||||
EV-to-Revenue | 6.17 | |||||
EV-to-Forward-Revenue | 5.21 | |||||
EV-to-FCF | 25.12 | |||||
Price-to-Projected-FCF | 3.31 | |||||
Price-to-Median-PS-Value | 1.65 | |||||
Price-to-Peter-Lynch-Fair-Value | 6.94 | |||||
Price-to-Graham-Number | 4.05 | |||||
Price-to-Net-Current-Asset-Value | 25.46 | |||||
Earnings Yield (Greenblatt) % | 2.92 | |||||
FCF Yield % | 4.13 | |||||
Forward Rate of Return (Yacktman) % | 8.84 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:DSKYF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daiichi Sankyo Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 11,266.556 | ||
EPS (TTM) ($) | 0.793 | ||
Beta | 0.11 | ||
Volatility % | 24.25 | ||
14-Day RSI | 58.47 | ||
14-Day ATR ($) | 3.368246 | ||
20-Day SMA ($) | 38.961985 | ||
12-1 Month Momentum % | 22.77 | ||
52-Week Range ($) | 23.45 - 42.91 | ||
Shares Outstanding (Mil) | 1,906.04 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Daiichi Sankyo Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Daiichi Sankyo Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Daiichi Sankyo Co Ltd Frequently Asked Questions
What is Daiichi Sankyo Co Ltd(DSKYF)'s stock price today?
The current price of DSKYF is $38.44. The 52 week high of DSKYF is $42.91 and 52 week low is $23.45.
When is next earnings date of Daiichi Sankyo Co Ltd(DSKYF)?
The next earnings date of Daiichi Sankyo Co Ltd(DSKYF) is 2024-11-07 Est..
Does Daiichi Sankyo Co Ltd(DSKYF) pay dividends? If so, how much?
The Dividend Yield %  of Daiichi Sankyo Co Ltd(DSKYF) is 0.85% (As of Today), Highest Dividend Payout Ratio of Daiichi Sankyo Co Ltd(DSKYF) was 0.91. The lowest was 0.35. And the median was 0.61. The  Forward Dividend Yield % of Daiichi Sankyo Co Ltd(DSKYF) is 1.01%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |